Article
DNA hypermethylation in breast cancer and its association with clinicopathological features.
Cancer letters - 18 Jun 2006
Li ShaoYing, Rong Minna, Iacopetta Barry
Abstract excerpt
Aberrant hypermethylation of gene promoter regions is one of the mechanisms for inactivation of tumour suppressor genes in breast cancer. We investigated whether hypermethylation identifies breast cancers with distinctive clinical and pathological features. We evaluated the methylation of RARbeta2, CDH1, ER, BRCA1, CCND2, p16 and TWIST in 193 breast carcinomas. Methylation frequencies ranged from 11% for CCND2 to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
